Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2005-11-22
pubmed:abstractText
Differentiation of embryonic stem (ES) cells generally occurs after formation of three-dimensional cell aggregates, known as embryoid bodies (EBs). This differentiation occurs following suspension culturing of EBs in media containing a high (25 mM) glucose concentration. Although high-glucose-containing media is used for maintenance and proliferation of ES cells, it has not been demonstrated whether this is a necessary requirement for EB development. To address this, we examined the growth and differentiation of EBs established in 0-mM, 5.5-mM (physiological), and 25-mM (high) glucose concentrations, through morphometric analysis and examination of gene and protein expression. The effect on EB development of supplementation with basic fibroblast growth factor (FGF2) was also studied. We report that the greatest rate of EB growth occurs in 5.5 mM glucose media. A morphological study of EBs over 104 days duration under glucose-containing conditions demonstrated the development of all three major embryonic cell types. The difference from normal human development was obvious in the lack of rostrocaudal control by the notochord. In the latest stages of development, the main tissue observed appeared to be cartilage and cells of a mesodermal lineage. We conclude that physiological glucose concentrations are suitable for the culturing of EBs, that the addition of FGF2 enhances the temporal expression of genes including POU5F1, nestin, FOXA2, ONECUT1, NEUROD1, PAX6, and insulin, and that EBs can be cultured in vitro for long periods, allowing for further examination of developmental processes.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Basic Helix-Loop-Helix..., http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Eye Proteins, http://linkedlifedata.com/resource/pubmed/chemical/FOXA2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2, http://linkedlifedata.com/resource/pubmed/chemical/Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Hepatocyte Nuclear Factor 3-beta, http://linkedlifedata.com/resource/pubmed/chemical/Hepatocyte Nuclear Factor 6, http://linkedlifedata.com/resource/pubmed/chemical/Homeodomain Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Intermediate Filament Proteins, http://linkedlifedata.com/resource/pubmed/chemical/NEUROD1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins, http://linkedlifedata.com/resource/pubmed/chemical/ONECUT1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Octamer Transcription Factor-3, http://linkedlifedata.com/resource/pubmed/chemical/PAX6 protein, http://linkedlifedata.com/resource/pubmed/chemical/POU5F1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Paired Box Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/Repressor Proteins, http://linkedlifedata.com/resource/pubmed/chemical/nestin
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0006-3363
pubmed:author
pubmed:issnType
Print
pubmed:volume
73
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1147-56
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16079311-Basic Helix-Loop-Helix Transcription Factors, pubmed-meshheading:16079311-Biological Markers, pubmed-meshheading:16079311-Cell Differentiation, pubmed-meshheading:16079311-Cell Lineage, pubmed-meshheading:16079311-Cell Proliferation, pubmed-meshheading:16079311-Cells, Cultured, pubmed-meshheading:16079311-Dose-Response Relationship, Drug, pubmed-meshheading:16079311-Embryo, Mammalian, pubmed-meshheading:16079311-Eye Proteins, pubmed-meshheading:16079311-Fibroblast Growth Factor 2, pubmed-meshheading:16079311-Gene Expression Regulation, pubmed-meshheading:16079311-Glucose, pubmed-meshheading:16079311-Hepatocyte Nuclear Factor 3-beta, pubmed-meshheading:16079311-Hepatocyte Nuclear Factor 6, pubmed-meshheading:16079311-Homeodomain Proteins, pubmed-meshheading:16079311-Humans, pubmed-meshheading:16079311-Insulin, pubmed-meshheading:16079311-Intermediate Filament Proteins, pubmed-meshheading:16079311-Nerve Tissue Proteins, pubmed-meshheading:16079311-Neurons, pubmed-meshheading:16079311-Octamer Transcription Factor-3, pubmed-meshheading:16079311-Paired Box Transcription Factors, pubmed-meshheading:16079311-Pancreas, pubmed-meshheading:16079311-Pluripotent Stem Cells, pubmed-meshheading:16079311-Repressor Proteins, pubmed-meshheading:16079311-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16079311-Stem Cells
pubmed:year
2005
pubmed:articleTitle
Growth and differentiation of embryoid bodies derived from human embryonic stem cells: effect of glucose and basic fibroblast growth factor.
pubmed:affiliation
Diabetes Transplant Unit, Prince of Wales Hospital and The University of New South Wales, Sydney, New South Wales 2031, Australia.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't